INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 78 filers reported holding INSTIL BIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,193 | +7.0% | 33,585 | +2.0% | 0.00% | – |
| Q4 2022 | $20,738 | -87.0% | 32,917 | -0.4% | 0.00% | -100.0% |
| Q3 2022 | $160,000 | +6.7% | 33,037 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $150,000 | -48.1% | 32,570 | +21.3% | 0.00% | -50.0% |
| Q1 2022 | $289,000 | -41.3% | 26,845 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $492,000 | +181.1% | 28,735 | +194.3% | 0.00% | +100.0% |
| Q3 2021 | $175,000 | -7.4% | 9,764 | -0.0% | 0.00% | 0.0% |
| Q2 2021 | $189,000 | – | 9,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $408,285,000 | 100.00% |
| CPMG Inc | 8,218,467 | $88,349,000 | 14.82% |
| VR Adviser, LLC | 6,865,076 | $73,800,000 | 11.96% |
| Vivo Capital, LLC | 12,486,787 | $134,233,000 | 9.24% |
| Samsara BioCapital, LLC | 1,991,950 | $21,413,000 | 5.39% |
| Fairmount Funds Management LLC | 673,905 | $7,244,000 | 1.71% |
| RA Capital Management | 4,870,793 | $52,361,000 | 1.14% |
| Nicholas Investment Partners, LP | 762,388 | $8,196,000 | 0.58% |
| HHLR ADVISORS, LTD. | 2,385,457 | $25,644,000 | 0.54% |
| Logos Global Management LP | 377,091 | $4,054,000 | 0.53% |